Search clinical trials for: placebo/valsartan
Total 54078 results
-
Novartis PharmaceuticalsCompleted
-
Shanghai Pharmaceuticals Holding Co., LtdRecruitingDiabetic Kidney DiseaseChina
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Austria, Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Denmark, Ecuador, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Italy, Malaysia, Mexico, Netherlands, Norway, Peru, Poland, Russian Federation and more
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
University of ZurichNovartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedHeart Failure With Preserved Ejection FractionColombia, Romania, United States, Austria, Belgium, Estonia, Turkey, Germany, Netherlands, Italy, Spain, Thailand, Argentina, France, Bulgaria, Hungary, Israel, Peru, Lithuania, Guatemala, India, Russian Federation, Denmark, Mexico, Slo... and more
-
Novartis PharmaceuticalsCompletedChronic Heart Failure (CHF)Spain, Croatia, Taiwan, Germany, Italy, United States, Australia, Netherlands, Switzerland, Belgium, United Kingdom, Bulgaria, Lithuania, Russian Federation, France, Argentina, Korea, Republic of, Poland, Canada, Turkey
-
LG Life SciencesCompleted
-
Horng ChenEnrolling by invitationChronic Kidney Diseases | Heart Failure With Preserved Ejection FractionUnited States
-
Forest LaboratoriesCompletedStage 2 Hypertension | Stage 1 HypertensionUnited States
-
Qingdao Central HospitalNot yet recruitingMyocardial Infarction | HypertensionChina
-
Novartis PharmaceuticalsCompletedChronic Heart Failure With Reduced Ejection FractionBelgium, Estonia, Denmark, Greece, United Kingdom, Germany, Latvia, Lithuania, Spain, Netherlands, Bulgaria, Finland, Poland, Czechia, Iceland, Sweden, France, Ireland, Norway
-
Novartis PharmaceuticalsCompletedCardiomyopathy, HypertrophicUnited States, Germany, United Kingdom, Spain, Korea, Republic of, Greece
-
Novartis PharmaceuticalsCompletedHeart Failure, Reduced Ejection FractionUnited States
-
Novartis PharmaceuticalsCompleted
-
Brigham and Women's HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
Novartis PharmaceuticalsCompletedEssential HypertensionJapan
-
NovartisCompleted
-
NovartisCompletedHypertensionSingapore, Hungary, Czech Republic, United Kingdom
-
Novartis PharmaceuticalsCompletedAcute Myocardial InfarctionChina, United States, South Africa, Italy, Spain, Croatia, Czechia, Hungary, Romania, Taiwan, Belgium, Germany, Netherlands, Austria, Denmark, United Kingdom, Thailand, Argentina, Israel, Australia, Bulgaria, France, Greece, Russian Federation and more
-
Ohio State UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingObesity | PreDiabetes | Blood Pressure | Impaired Glucose ToleranceUnited States
-
NovartisThe TIMI Study GroupCompletedMyocardial Ischemia | Post Acute Coronary SyndromeGermany, Spain, United States, Belgium, Canada, Czech Republic, Hungary, Netherlands, Poland, Russian Federation, Sweden
-
Chongqing Medical UniversityNot yet recruitingHeart Failure With Preserved Ejection FractionChina
-
Jacob MollerOdense University Hospital; Rigshospitalet, Denmark; Danish Heart FoundationRecruitingMyocardial Infarction | Diastolic DysfunctionDenmark
-
Duke UniversityNovartis PharmaceuticalsCompleted
-
Wake Forest University Health SciencesJohns Hopkins UniversityTerminatedHIV | Sarcopenia | Aging | Angiotensin Receptor AntagonistsUnited States
-
Damanhour UniversityTanta UniversityCompleted
-
Clinical Hospital Heliodor Swiecicki of the Medical...Medical University of Silesia; Medical University of Gdansk; Medical University... and other collaboratorsRecruiting
-
The University of Hong KongRecruiting
-
Massachusetts General HospitalRecruitingHIV/AIDS | Heart Failure With Preserved Ejection FractionUnited States
-
Yuhan CorporationCompletedHypertension | HyperlipidemiaKorea, Republic of
-
Novartis PharmaceuticalsCompletedHeart Failure With Preserved Ejection Fraction (HFpEF)United States, Canada
-
University of WashingtonNational Heart, Lung, and Blood Institute (NHLBI)RecruitingPulmonary Arterial Hypertension | Right Ventricular Dysfunction | Right Heart Failure | Pulmonary Vascular DisorderUnited States
-
Novartis PharmaceuticalsCompletedHypertensionSweden, Belgium, Hungary, India, Italy, Poland, Turkey, United States, Brazil, France, South Africa
-
University of Alabama at BirminghamNational Heart, Lung, and Blood Institute (NHLBI)RecruitingCardiovascular Diseases | Diabetes Mellitus | Insulin Sensitivity/Resistance | Metabolic Disease | Energy Expenditure | Metabolism | Natriuretic PeptidesUnited States
-
Montreal Heart InstituteNovartis PharmaceuticalsTerminatedHeart Failure | Systemic Right VentricleCanada
-
University of Alabama at BirminghamNational Heart, Lung, and Blood Institute (NHLBI)RecruitingCardiovascular Diseases | Hypertension | Obesity | Nocturnal Blood Pressure | Natriuretic Peptides | Renin-Angiotensin-Aldosterone SystemUnited States
-
Novartis PharmaceuticalsRecruitingHeart FailureItaly, Spain, United States, Japan, China, Germany, Taiwan, Bulgaria, Denmark, France, Portugal, Slovakia
-
TakedaCompletedEssential HypertensionChina
-
NovartisCompleted
-
Viatris Inc.Not yet recruiting
-
Radboud University Medical CenterTerminatedSevere Acute Respiratory Syndrome | COVID-19 | COVID | Acute Respiratory Distress Syndrome | SARS-CoV-2Netherlands
-
Medical University of SilesiaPolpharma Pharmaceutical CompanyTerminatedFirst Time Dual Chamber Pacemaker ImplantationPoland
-
Novartis PharmaceuticalsCompleted
-
Hannover Medical SchoolDLR German Aerospace CenterWithdrawn
-
LanZhou UniversityUnknown
-
The Children's Hospital of Zhejiang University...UnknownHenoch Schönlein Purpura NephritisChina
-
Kitakyushu-Tsuyazaki HospitalCompleted
-
Emory UniversityCompletedAtherosclerosis | Carotid Artery DiseasesUnited States
-
Novartis PharmaceuticalsCompletedHeart Failure and Reduced Ejection FractionUnited States